Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Transplantation for Hematologic Malignancies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01814475
What this trial is testing

Study to Compare Busulfan-fludarabine With Thiotepa-fludarabine Regimen in Allogeneic Transplantation for Myelofibrosis

Who this might be right for
Myelofibrosis
Gruppo Italiano Trapianto di Midollo Osseo 62
Testing effectiveness (Phase 2)Study completedNCT00003336
What this trial is testing

Pilot Study Of Unrelated UCB Transplant for Non-Malignant Hematologic Conditions

Who this might be right for
LeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Diseases
Case Comprehensive Cancer Center 6
Early research (Phase 1)Temporarily pausedNCT03494569
What this trial is testing

Total Marrow and Lymphoid Irradiation, Fludarabine, and Melphalan Before Donor Stem Cell Transplant in Treating Participants With High-Risk Acute Leukemia or Myelodysplastic Syndrome

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Lymphoblastic Leukemia in RemissionAcute Myeloid Leukemia+5 more
City of Hope Medical Center 36
Testing effectiveness (Phase 2)UnknownNCT01423175
What this trial is testing

ClAraC or FLAMSA Followed by Stem Cell Transplantation to Treat High Risk AML or Advanced MDS

Who this might be right for
Acute Myeloid LeukemiaMDS
Hannover Medical School 60
Early research (Phase 1)Study completedNCT00001830
What this trial is testing

Donor Th2 Cells to Prevent Graft-Versus-Host Disease in Bone Marrow Transplants

Who this might be right for
Chronic Lymphocytic LeukemiaGraft vs Host DiseaseHodgkin's Disease+2 more
National Cancer Institute (NCI) 110
Testing effectiveness (Phase 2)Study completedNCT00002831
What this trial is testing

Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous or Acute Leukemia

Who this might be right for
Leukemia
M.D. Anderson Cancer Center 24
Large-scale testing (Phase 3)Looking for participantsNCT06918002
What this trial is testing

Elranatamab/Lenalidomide Consolidation and/or Elranatamab Maintenance Versus Standard of Care After D-VRd Induction in Transplant-eligible NDMM Patients

Who this might be right for
Multiple Myeloma, Newly Diagnosed
Intergroupe Francophone du Myelome 824
Testing effectiveness (Phase 2)WithdrawnNCT03003728
What this trial is testing

2015-10: Expanded Natural Killer Cells and Elotuzumab for High-Risk Myeloma Post- Autologous Stem Cell Transplant (ASCT)

Who this might be right for
Multiple Myeloma
University of Arkansas
Testing effectiveness (Phase 2)Study completedNCT05561751
What this trial is testing

Ph2, Study to Assess the Safety and Efficacy of GPC 100 and Propranolol With and Without G-CSF for the Mobilization of Stem Cells in Patients With Multiple Myeloma Undergoing Autologous Stem Cell Transplant

Who this might be right for
Multiple Myeloma
GPCR Therapeutics, Inc. 30
Not applicableStudy completedNCT01576653
What this trial is testing

Prospective Clinical Evaluation of Beta-D-Glucan Assay in Blood and BAL

Who this might be right for
Invasive Fungal InfectionHematological MalignancyReceipt of Solid Organ Transplant
Robert Krause, MD 100
Large-scale testing (Phase 3)Ended earlyNCT00083564
What this trial is testing

Study Comparing STR (Skeletal Targeted Radiotherapy) Plus Melphalan to Melphalan Alone, With Stem Cell Transplant in Multiple Myeloma

Who this might be right for
Multiple Myeloma
Poniard Pharmaceuticals 240
Early research (Phase 1)WithdrawnNCT04466475
What this trial is testing

Radioimmunotherapy (211At-OKT10-B10) and Chemotherapy (Melphalan) Before Stem Cell Transplantation for the Treatment of Multiple Myeloma

Who this might be right for
Plasma Cell Myeloma
Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT03434730
What this trial is testing

Tocilizumab for the Prevention of Graft Versus Host Disease After Cord Blood Transplantation

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaAcute Leukemia+6 more
Memorial Sloan Kettering Cancer Center 46
Not applicableEnded earlyNCT00578292
What this trial is testing

Allogeneic Stem Cell Transplantation, Severe Homzygous 0/+Thalassemia or Sever Variants of Beta 0/+ Thalassemia, THALLO

Who this might be right for
Thalassemia
Baylor College of Medicine 10
Not applicableStudy completedNCT01385787
What this trial is testing

MRD Testing Before and After Hematopoietic Cell Transplantation for Pediatric Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
Center for International Blood and Marrow Transplant Research 150
Testing effectiveness (Phase 2)Looking for participantsNCT06315309
What this trial is testing

Trial of 2 Step ATG for Acute GVHD Prevention Post Myeloablative Allogeneic Stem Cell Transplant

Who this might be right for
GVHD,AcuteAcute LeukemiaMyelodysplastic Syndromes+1 more
University of Alabama at Birmingham 29
Testing effectiveness (Phase 2)Study completedNCT00862719
What this trial is testing

Sitagliptin Umbilical Cord Blood Transplant Study

Who this might be right for
Leukemia, Myeloid, AcuteAcute Lymphoblastic LeukemiaMyelodysplasia+2 more
Indiana University 29
Testing effectiveness (Phase 2)Study completedNCT00105001
What this trial is testing

Tacrolimus and Mycophenolate Mofetil With or Without Sirolimus in Preventing Acute Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer

Who this might be right for
Myelodysplastic/Myeloproliferative Neoplasm, UnclassifiablePreviously Treated Myelodysplastic SyndromeRefractory Chronic Lymphocytic Leukemia+113 more
Fred Hutchinson Cancer Center 210
Not applicableStudy completedNCT00195533
What this trial is testing

Study Comparing Piperacillin-tazobactam Versus Piperacillin-tazobactam Plus Glycopeptide in Neutropenic Patients

Who this might be right for
Hematological MalignancyLeukemiaMyelodysplasia+3 more
Wyeth is now a wholly owned subsidiary of Pfizer 801
Testing effectiveness (Phase 2)Study completedNCT00556452
What this trial is testing

Study of Stem Cell Transplantation for Hematologic Malignancies Using Clofarabine and Busulfan Regimen

Who this might be right for
LeukemiaHodgkin LymphomaNon-Hodgkin Lymphoma+2 more
University of Michigan Rogel Cancer Center 46
Next Page